Par Pharmaceutical (PRX) agrees to be acquired by TPG for $50/share
Tweet
Share
E-mailGet Alerts PRX Hot Sheet
Join SI Premium – FREE
Par Pharmaceutical (NYSE: PRX) agrees to be acquired by TPG for $50/share
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Holcim to acquire Fermacell from James Hardie for EUR 840M
- Bernstein on whether Hershey (HSY) could eventually step up to buy Mondelez (MDLZ)
- Value-focused retailer sees traffic momentum strengthen ahead of second quarter
Create E-mail Alert Related Categories
Hot List, Hot M&A, Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
